METHOFILL SELF-DOSE INJECTOR
ACCORD HEALTHCARE INC
Quick answers
Is there a shortage of METHOFILL SELF-DOSE INJECTOR in Canada?
No. There is no current shortage of METHOFILL SELF-DOSE INJECTOR 22.5MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
METHOTREXATE INJECTION USP
PFIZER CANADA ULC
METHOTREXATE SODIUM INJECTION USP
PFIZER CANADA ULC
METHOTREXATE INJECTION, BP
PHARMASCIENCE INC
METOJECT
MEDEXUS PHARMACEUTICALS INC.
METHOTREXATE PF/SA INJECTION
SANDOZ CANADA INCORPORATED
METOJECT SUBCUTANEOUS
MEDEXUS PHARMACEUTICALS INC.
DIN
02530848
Strength
22.5MG
Dosage Form
Solution
Route
Subcutaneous
Active Ingredient
METHOTREXATE (METHOTREXATE SODIUM)
See all METHOTREXATE (METHOTREXATE SODIUM) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from ACCORD HEALTHCARE INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
5MG · DIN 02381478
10MG · DIN 02381486
70MG · DIN 02381494
5MG · DIN 02419564
2.5MG · DIN 02419556
10MG · DIN 02419572
1MG · DIN 02351218
5MG · DIN 02487721
2.5MG · DIN 02487713
40MG · DIN 02457776
80MG · DIN 02457784
10MG · DIN 02457741